O
BIO icon

Ossiam’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ossiam’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-70
Closed -$23K – 621
2024
Q4 		$23K Sell
70
-472
-87% -$160K ﹤0.01% 598
2024
Q3 		$181K Sell
542
-242
-31% -$76.9K ﹤0.01% 546
2024
Q2 		$214K Buy
784
+40
+5% +$11.6K ﹤0.01% 529
2024
Q1 		$257K Buy
744
+264
+55% +$86.8K ﹤0.01% 556
2023
Q4 		$155K Buy
480
+4
+0.8% +$1.25K ﹤0.01% 604
2023
Q3 		$171K Sell
476
-131
-22% -$50.5K ﹤0.01% 611
2023
Q2 		$230K Buy
607
+307
+102% +$125K ﹤0.01% 586
2023
Q1 		$144K Buy
300
+16
+6% +$7.49K ﹤0.01% 533
2022
Q4 		$119K Hold
284
– – ﹤0.01% 545
2022
Q3 		$118K Buy
284
+256
+914% +$128K ﹤0.01% 533
2022
Q2 		$14K Sell
28
-3,864
-99% -$2.01M ﹤0.01% 406
2022
Q1 		$2.19M Buy
3,892
+3,823
+5,541% +$2.3M 0.06% 169
2021
Q4 		$52K Buy
69
+48
+229% +$35.9K ﹤0.01% 389
2021
Q3 		$16K Hold
21
– – ﹤0.01% 421
2021
Q2 		$16K Buy
+21
New +$12.8K ﹤0.01% 426
2021
Q1 		– Sell
-1,147
Closed -$669K – 415
2020
Q4 		$669K Sell
1,147
-420
-27% -$239K 0.02% 242
2020
Q3 		$808K Sell
1,567
-1,268
-45% -$642K 0.03% 208
2020
Q2 		$1.28M Buy
+2,835
New +$1.25M 0.08% 149

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ossiam's BIO Position: Q1 2025 in Review

Ossiam sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 70 shares — an estimated $23K sold.

Ossiam first reported a position in BIO in Q2 2020 and held it in 18 quarters. The position peaked at $2.19M in Q1 2022. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Ossiam reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Ossiam sold 70 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $23K.
  • Ossiam first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 18 quarters.
  • Ossiam's Bio-Rad Laboratories Class A position peaked at $2.19M in Q1 2022.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Ossiam's 13F filing for Q1 2025, filed 14 May 2025.